Menu

Blog

Archive for the ‘biotech/medical’ category: Page 345

Aug 7, 2023

New Vaccine Technology Controls Malaria

Posted by in categories: biotech/medical, genetics

Malaria is a possibly fatal disease caused by a parasite transferred by mosquitos to humans. Common symptoms include fever, chills, and flu-like traits. According to the Centers for Disease Control (CDC), around 2,000 cases of malaria are diagnosed in the United States per year. The diagnosis is common in individuals coming back from Africa or Asia. On a global scale, about 700,000 people die from malaria, and most are children. However, death from malaria can usually be prevented with early detection and proper medical care. Researchers are trying to proactively target malaria by developing a new vaccine using genetic material.

Researchers from the Victoria University of Wellington’s Ferrier Research Institute, the Malaghan Institute of Medical Research, and the Peter Doherty Institute for Infection and Immunity have all worked together to develop a vaccine that can effectively stimulate cells in the immune system against malaria-causing parasite, Plasmodium. The vaccine, described in Nature Immunology, is designed to generate resident memory cells in the liver to combat Plasmodium. Resident memory cells are a type of immune cell that reside in tissues throughout the body to target invading pathogens that enter those tissues.

The vaccine is made with messenger ribonucleic acid (mRNA), as opposed to peptides or proteins. The difference between the two is the type of material delivered by the vaccine. Peptide-based vaccines use peptides from the virus to elicit an immune response. Alternatively, mRNA vaccines use mRNA extracted from the virus. In this study, the researchers originally used a peptide-based vaccine but recently found mRNA improves the activation of resident immune cells to kill malaria-based pathogens. The treatment result was significant between the two types of vaccines because the peptide-based vaccine had small fragments of protein and could not stimulate the immune system effectively, while the mRNA could encode for an entire malaria protein.

Aug 7, 2023

How does the circulating proteome influence brain health?

Posted by in categories: biotech/medical, health, neuroscience

A recent study posted to the medRxiv preprint server investigates the association between the circulating proteome and brain health.

Study: The circulating proteome and brain health: Mendelian randomisation and cross-sectional analyses. Image Credit: Abduramanova Elena / Shutterstock.com.

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Aug 7, 2023

Why NASA spacesuits are white

Posted by in category: biotech/medical

Narrator: Here on Earth, our atmosphere shields us from 77% of the sun’s radiation. But astronauts in space don’t have that natural shield, making them vulnerable to blistering temperatures, severe sunburn, and even cancer-causing cell damage. So to combat that, they wear white suits that reflect the sun’s harmful radiation. It’s just like how painting a wall white keeps the room cooler than a dark color because lighter paint absorbs 35% less heat.

Cathleen Lewis: It’s the ideal color to keep the astronauts safe. If you’re planning to go out in outer space, that reflective nature is an absolute.

Narrator: But those white EVA suits aren’t the only garment in an astronaut’s closet. When heading into space or coming home, NASA astronauts wear a bright orange suit similar in color to the safety vests Air Force pilots wear, and it’s for similar reasons because that loud orange stands out against the blue ocean and sky and is perfect for attracting attention, so if there’s a malfunction during landing and astronauts have to abandon ship, so to speak, they need to be easy to spot for rescue crews. That’s why orange was the color of choice for missions like Russia’s Vostok program as well as current ISS launch and reentry suits.

Aug 6, 2023

DNA-origami-directed virus capsid polymorphism

Posted by in categories: biotech/medical, nanotechnology

Seitz et al. use DNA origami as a scaffold for viral capsid proteins to create virus capsids in the shapes of rings, tubes, and more! They employ cryo-EM to obtain 3D structures of some of their nanomolecular constructs and they show that multi-layer capsids occur at high concentrations of capsid proteins. Exciting work! #nanotechnology #biotechnology #syntheticbiology #genetherapy


DNA and RNA origami nanostructures direct the size, shape and topology of different virus capsids in a user-defined manner while shielding encapsulated origamis from degradation.

Aug 6, 2023

First CRISPR’d cockroaches open door to other gene-edited insects

Posted by in categories: biotech/medical, genetics

It’s now easier for scientists to create gene-edited insects thanks to a new technique called “direct parental CRISPR.”

Aug 6, 2023

Revolutionizing Optical Imaging With Complex-Domain Neural Networks

Posted by in categories: biotech/medical, robotics/AI

Computational imaging holds the promise of revolutionizing optical imaging with its wide field of view and high-resolution capabilities. Through the joint reconstruction of amplitude and phase — a technique known as “coherent imaging or holographic imaging” — the throughput of an optical system can expand to billions of optically resolvable spots. This breakthrough empowers researchers to gain crucial insights into cellular and molecular structures, making a significant impact on biomedical research.

Despite the potential, existing large-scale coherent imaging techniques face challenges hindering their widespread clinical use. Many of these techniques require multiple scanning or modulation processes, resulting in long data collection times to achieve a high resolution and signal-to-noise ratio. This slows down imaging and limits its feasibility in clinical settings due to tradeoffs between speed, resolution, and quality.

Aug 6, 2023

There Was A NASTY Illegal Lab Situation In California

Posted by in categories: bioengineering, biotech/medical, government

A makeshift lab in Fresno, California was illegally storing over 1,000 bioengineered mice and disease samples. Ana Kasparian and Wosney Lambre discuss on The Young Turks. https://shoptyt.com/collections/justice-is-coming.

Watch TYT LIVE on weekdays 6–8 pm ET. http://youtube.com/theyoungturks/live.

Continue reading “There Was A NASTY Illegal Lab Situation In California” »

Aug 6, 2023

Scientists Regrow Retinal Cells in The Lab Using Nanotechnology

Posted by in categories: biotech/medical, nanotechnology, neuroscience, Ray Kurzweil, singularity

Still a big maybe but it gives them other ideas/possibilities. Hopefully they succeed soon! My mother has glaucoma. It’ll probably be decades before this cure happens though. Unless it can be accelerated which is predicted by Ray Kurzweil in his book The Singularity is Near. I think other futurists have said similar things though I’m not familiar with all of them, I saw a talk by one for NASA.


In efforts to tackle the leading cause of blindness in developed countries, researchers have recruited nanotechnology to help regrow retinal cells.

Macular degeneration is a form of central vision loss, which has massive social, mobility, and mental consequences. It impacts hundreds of millions of people globally and is increasing in prevalence.

Continue reading “Scientists Regrow Retinal Cells in The Lab Using Nanotechnology” »

Aug 6, 2023

Tryptophan + Niacin: No Additive Effect On NAD, Relative To Niacin Alone

Posted by in categories: biotech/medical, genetics

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.

Continue reading “Tryptophan + Niacin: No Additive Effect On NAD, Relative To Niacin Alone” »

Aug 6, 2023

Gene Therapies for Eternal Youth

Posted by in categories: biotech/medical, life extension

Now fast forward 10 more years. That same man and his peers will have counted 70 circles round the sun. But John will remain biologically 60. At the same time, someone who is 30 years old in the year 2033 could theoretically begin the therapy at age 30, and stick at a biological age of 30 for the next 30 years, when their calendar would call them 60. That’s what gene therapies for longevity could do.


Longevity startups are riding high as a wave of gene therapies advance through clinical trials. Can they actually turn back the clock?

So far, gene therapy has been approved by the U.S. Food and Drug Administration (FDA) for only a couple of applications like rare inherited diseases and blood cancer. That said, more than 2,000 clinical trials are taking place in 2023, with 200 of them having already reached phase 3 clinical trials. A slew of upcoming gene therapies could be approved—possibly in the months to come—in the United States and Europe, targeting everything from sickle cell disease and hemophilia to metastatic skin cancer. In this future, gene therapy will be approved for everything we can imagine—and many things we can’t.

Page 345 of 2,560First342343344345346347348349Last